Related Experiment Video
Updated: Jul 22, 2026

10:47
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
Substituted carboranes and polyhedral hydroborate salts as anti-neoplastics
I H Hall1, A Elkins, W J Powell
1Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360, USA.
Anticancer Research
|August 15, 1998
Summary
Substituted carboranes show potent anti-cancer activity against various leukemias and solid tumors. These compounds, like amino-o-carborane-hydrochloride 7, target DNA synthesis by inhibiting key enzymes in purine synthesis.
Area of Science:
- Medicinal Chemistry
- Oncology
- Biochemistry
Background:
- Substituted carboranes and polyhedral hydroborate salts exhibit anti-neoplastic and cytotoxic properties.
- These compounds have demonstrated efficacy against a range of cancers, including leukemias, adenocarcinomas, and gliomas.
Purpose of the Study:
- To investigate the anti-cancer potential of substituted carboranes and polyhedral hydroborate salts.
- To elucidate the mechanism of action of potent compounds like amino-o-carborane-hydrochloride 7 on cancer cell DNA synthesis.
Main Methods:
- In vitro assessment of cytotoxic and anti-neoplastic activity against various cancer cell lines.
- Analysis of the effects of amino-o-carborane-hydrochloride 7 on DNA synthesis in Tmolt3 cells.
- Enzyme activity assays to determine the inhibition targets of the carborane compounds.
Main Results:
- Amino-o-carborane-hydrochloride 7 preferentially inhibited Tmolt3 DNA synthesis.
- The compound targeted de novo purine synthesis by inhibiting PRPP-amido transferase and inosine monophosphate dehydrogenase.
- Dihydrofolate reductase and nucleoside kinase activities were also inhibited, leading to reduced deoxyribonucleotide pools.
Conclusions:
- Substituted carboranes are effective anti-cancer agents targeting critical enzymes in nucleotide biosynthesis.
- Amino-o-carborane-hydrochloride 7 represents a promising lead compound for further development in cancer therapy.
- The mechanism involves disruption of DNA synthesis through inhibition of purine and pyrimidine pathways.

